Current Research

Latest News

Light-activated Hydrogels to the Rescue:

Grinstaff Lab highlighting the promise of light-activated hydrogels for cartilage repair and potential use in osteoarthritis therapy featured in Chemistry Views and C&EN .
Read the full C&EN article here and the Chemistry Views article here.

Two-Step Delivery of Cancer Drugs Using Responsive Nanoparticles

Findings of collaborative research between Grinstaff Lab at BU and Colson lab at BWH were published in Scientific Reports and highlighted in C&EN review here.



Mark Grinstaff Receives Inaugural DeLisi Award

The College of Engineering has honored interdisciplinary scientist, Professor Mark Grinstaff (Chemistry, BME, MSE, MED), with the inaugural Charles DeLisi Award and Distinguished Lecture.

The award – established by a generous gift by Professor and Dean Emeritus Charles DeLisi, widely considered the father of the Human Genome Project – is in recognition of Mark Grinstaff’s significant contributions to his field, both as an academic researcher and as an entrepreneur who has co-founded four companies that are translating his ideas into clinical products. He was also named a College of Engineering Distinguished Faculty Fellow and a Kern Faculty Fellow.

The Group is featured in BU Today!

From Grad Students to Groundbreakers: You can read the article here.

About The Group

The Grinstaff Group pursues highly interdisciplinary research in the areas of biomedical engineering and macromolecular chemistry. The major goal in these research projects is to elucidate the underlying fundamental chemistry and engineering principles and to use that insight to direct our creative and scientific efforts.


read more about Mark Grinstaff

Latest News

Mark Grinstaff Receives Inaugural DeLisi Award

The College of Engineering has honored interdisciplinary scientist, Professor Mark Grinstaff (Chemistry, BME, MSE, MED), with the inaugural Charles DeLisi Award and Distinguished Lecture.

The award – established by a generous gift by Professor and Dean Emeritus Charles DeLisi, widely considered the father of the Human Genome Project – is in recognition of Mark Grinstaff’s significant contributions to his field, both as an academic researcher and as an entrepreneur who has co-founded four companies that are translating his ideas into clinical products. He was also named a College of Engineering Distinguished Faculty Fellow and a Kern Faculty Fellow.

The Group is featured in BU Today!

From Grad Students to Groundbreakers: You can read the article here.

About The Group

The Grinstaff Group pursues highly interdisciplinary research in the areas of biomedical engineering and macromolecular chemistry. The major goal in these research projects is to elucidate the underlying fundamental chemistry and engineering principles and to use that insight to direct our creative and scientific efforts.


read more about Mark Grinstaff